Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

ABBOTT LABORATORIES : Ex-dividend day for

share with twitter share with LinkedIn share with facebook
10/14/2020 EDT

A dividend is removed today from Abbott Laboratories's share.


© Factset 2020

share with twitter share with LinkedIn share with facebook
All news about ABBOTT LABORATORIES
09:17aABBOTT LABORATORIES : Reports third-quarter 2020 results, achieves strong double..
AQ
10/21ABBOTT LABORATORIES : Raises 2020 Earnings Guidance
DJ
10/21ABBOTT LABORATORIES : 3Q Profit, Sales Rise on Covid-19 Testing
DJ
10/21Abbott says COVID-19 test demand to grow in 2021
RE
10/21ABBOTT : 3Q Earnings Snapshot
AQ
10/21ABBOTT LABORATORIES : Results of Operations and Financial Condition, Financial S..
AQ
10/21Abbott quarterly profit rises 28.3% on strong sales of COVID-19 tests
RE
10/21ABBOTT : Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnin..
PR
10/20ABBOTT LABORATORIES : - improved mental and physical condition is directly linke..
AQ
10/20CYBERTHEFT LAWSUIT : ERISA Fiduciary Breach Claims Dismissed Against Plan Sponso..
AQ
More news
Financials (USD)
Sales 2020 33 554 M - -
Net income 2020 4 483 M - -
Net Debt 2020 11 202 M - -
P/E ratio 2020 43,7x
Yield 2020 1,37%
Capitalization 188 B 188 B -
EV / Sales 2020 5,92x
EV / Sales 2021 5,12x
Nbr of Employees 107 000
Free-Float 88,8%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 118,61 $
Last Close Price 105,93 $
Spread / Highest target 28,4%
Spread / Average Target 12,0%
Spread / Lowest Target -22,6%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES21.95%187 552
MEDTRONIC PLC-3.72%146 850
BECTON, DICKINSON AND COMPANY-13.08%68 525
HOYA CORPORATION16.94%43 777
BAXTER INTERNATIONAL INC.-2.25%41 379
DEXCOM, INC.77.31%37 133